Effectiveness of radiation therapy in GIST: A case report

Journal of Gastrointestinal Oncology

Volumn 3, Issue 2, 2012, Pages 143-146

  Halpern, Joshua ^a   Kim, Yong June ^a   Sultana, Rumana ^a   Villani, Gina ^a  

^a BROOKLYN HOSPITAL CENTER   (United States)

Author keywords

Gastrointestinal stromal tumor (GIST); Imatinibmesylate Mesenchymal tumor; Intensity modulated radiation therapy (IMRT); Radiation therapy

Indexed keywords

IMATINIB;

ABDOMINAL MASS; ADULT; AFRICAN AMERICAN; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DISEASE DURATION; DRUG WITHDRAWAL; FLUID RETENTION; GALLSTONE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INTENSITY MODULATED RADIATION THERAPY; LEG EDEMA; LOWER ABDOMINAL PAIN; MALE; NAUSEA; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; RADIATION DOSE; SIDE EFFECT; TREATMENT RESPONSE; TUMOR VOLUME; URINARY FREQUENCY; WEIGHT REDUCTION;

EID: 84995755345     PISSN: 20786891     EISSN: 2219679X     Source Type: Journal    
DOI: 10.3978/j.issn.2078-6891.2011.046     Document Type: Article

References (31)

1. Mazur MT, Clark HB. Gastr ic stroma l tumors. Reappra isa l of histogenesis. Am J Surg Pathol 1983;7:507-19.
2. Stamatakos M, Douzinas E, Stefanaki C, Safioleas P, Polyzou E, Levidou G, et al. Gastrointestinal stromal tumor. World J Surg Oncol 2009;7:61.
3. Perez EA, Livingstone AS, Franceschi D, Rocha-Lima C, Lee DJ, Hodgson N, et al. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg 2006;202:623-9.
4. Badalamenti G, Rodolico V, Fulfaro F, Cascio S, Cipolla C, Cicero G, et al. Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features. Ann Oncol 2007;18 Suppl 6:vi136-40.
5. Aubin F, Blanke CD. Metastatic gastrointestinal stromal tumors. Cancer Chemother Pharmacol 2011;67 Suppl 1:S9-14.
6. Byrd D, Blancke C. Gastrointestinal stromal tumors. Liver metastases 2009;137-8.
7. Gajiwala KS, Wu JC, Christensen J, Deshmukh GD, Diehl W, DiNitto JP, et al. KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients. Proc Natl Acad Sci U S A 2009;106:1542-7.
8. Joensuu H, Kindblom LG. Gastrointestinal stromal tumors-a review. Acta Orthop Scand Suppl 2004;75:62-71.
9. Papaetis GS, Syrigos KN. Targeted therapy for gastrointestinal stromal tumors: current status and future perspectives. Cancer Metastasis Rev 2010;29:151-70.
10. Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol 2004;11:465-75.
11. Pisters PW, Patel SR. Gastrointestinal stromal tumors: current management. J Surg Oncol 2010;102:530-8.
12. Pollock J, Morgan D, Denobile J, Williams J. Adjuvant radiotherapy for gast rointest ina l st roma l tumor of the rectum. Dig Dis Sci 2001;46:268-72.
13. Siehl J, Thiel E. C-kit, GIST, and imatinib. Recent Results Cancer Res 2007;176:145-51.
14. Howe JR, Karnell LH, Scott-Conner C. Small bowel sarcoma: analysis of survival from the National Cancer Data Base. Ann Surg Oncol 2001;8:496-508.
15. Van der Zwan SM, DeMatteo RP. Gastrointestinal stromal tumor: 5 years later. Cancer 2005;104:1781-8.
16. Gupta P, Tewari M, Shukla HS. Gastrointestinal stromal tumor. Surg Oncol 2008;17:129-38.
17. Arolfo S, Teggia PM, Nano M. Gastrointestinal stromal tumors: thirty years experience of an institution. World J Gastroenterol 2011;17:1836-9.
18. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-8.
19. Duffaud F, Salas S, Huyn T, Deville JL. Imatinib as the first and only treatment in Europe for adult patients at significant risk of relapse following gastrointestinal stromal tumor removal. Clinical and Experimental Gastroenterology 2010;3:41-7.
20. Joensuu H. Gastrointestinal stromal tumor (GIST). Ann Oncol 2006;17 Suppl 10:x280-6.
21. Papalambros A, Petrou A, Brennan N, Bramis K, Felekouras E, Papalambros E. GIST suture-line recurrence at a gastrojejunal anastomosis 8 years after gastrectomy: can GIST ever be described as truly benign? A case report. World J Surg Oncol 2010;8:90.
22. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006;30:477-89.
23. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999;23:377-89.
24. Urbańczyk K, Limon J, Korobowicz E, Chosia M, Sygut J, Karcz D, et al. Gastrointestinal stromal tumors. A multicenter experience. Pol J Pathol 2005;56:51-61.
25. Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001;136:383-9.
26. Demetri GD, Von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-80.
27. Blay JY, Le Cesne A, Ray-Coquard I, Bui B, Duffaud F, Delbaldo C, et al. Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group. J Clin Onc 2007;25:1107-13.
28. Blay JY, Adenis A, Ray-Coquard I, Cassier PA, Le Cesne A. Is there a role for discontinuing imatinib in patients with advanced gastrointestinal stromal tumour? Curr Opin Oncol 2009;21:360-6.
29. Nannini M, Biasco G, Pallotti MC, Di Battista M, Santini D, Paterini P, et al. Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. Med Oncol 2011.
30. Ciresa M, D'Angelillo RM, Ramella S, Cellini F, Gaudino D, Stimato G, et al. Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report. Tumori 2009;95:236-9.
31. Nishida T, Omori T, Ueshima S. Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitorsimatinib and sunitinib. Gan To Kagaku Ryoho 2011;38:733-7.